Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection
Patients undergo first doses of GE HealthCare's PET radiotracer Flyrcado (flurpiridaz F 18) injection at early adopter sites ...
Hosted on MSN1d
GE HealthCare delivers first PET MPI agent doses for CAD detection
GE HealthCare has delivered the initial subject doses of a positron emission tomography (PET) myocardial perfusion imaging ...
GE HealthCare announces first patient doses of Flyrcado for CAD detection
GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...
GE HealthCare projects $4.61-$4.75 adjusted EPS for 2025 amid margin expansion and Flyrcado launch
Q4 2024 Management View CEO Peter Arduini highlighted robust orders growth across all segments, with a record backlog of $19.8 billion. He emphasized the U.S. market strength, driven by outpatient ...
Investing23d
GE HealthCare Technologies Inc (GEHC)
ARLINGTON HEIGHTS, Ill. - GE HealthCare (NASDAQ: NASDAQ:GEHC) has received U.S. Food and Drug Administration (FDA) approval for Flyrcado™ (flurpiridaz F 18) injection, a new... ByInvesting.com ...